Citations for
1SLC25A46
Neuron-specific knockdown of solute carrier protein SLC25A46a induces locomotive defects, an abnormal neuron terminal morphology, learning disability, and shortened lifespan.
Ali MS, Suda K, Kowada R, Ueoka I, Yoshida H, Yamaguchi M.
IBRO Rep. Feb 19;8:65-75. doi: 10.1016/j.ibror.2020.02.001. eCollection 2020 Jun. 2020
2HMN6B, SLC25A46
Insights into the genotype-phenotype correlation and molecular function of SLC25A46.
Abrams AJ, Fontanesi F, Tan NBL, Buglo E, Campeanu IJ, Rebelo AP, Kornberg AJ, Phelan DG, Stark Z, Zuchner S.
Hum Mutat. Dec;39(12):1995-2007. doi: 10.1002/humu.23639. Epub 2018 Sep 17. 2018
3HMN6B, SLC25A46
Loss of SLC25A46 causes neurodegeneration by affecting mitochondrial dynamics and energy production in mice.
Li Z, Peng Y, Hufnagel RB, Hu YC, Zhao C, Queme LF, Khuchua Z, Driver AM, Dong F, Lu QR, Lindquist DM, Jankowski MP, Stottmann RW, Kao WWY, Huang T.
Hum Mol Genet. Oct 1;26(19):3776-3791. doi: 10.1093/hmg/ddx262. 2017
4HMN6B, SLC25A46
Novel pathogenic SLC25A46 splice-site mutation causes an optic atrophy spectrum disorder.
Nguyen M, Boesten I, Hellebrekers DM, Mulder-den Hartog NM, de Coo IF, Smeets HJ, Gerards M.
Clin Genet. Jan;91(1):121-125. doi: 10.1111/cge.12774. Epub 2016 Apr 8 2017
5MFN2, OPA1, SLC25A46
SLC25A46 is required for mitochondrial lipid homeostasis and cristae maintenance and is responsible for Leigh syndrome
Janer A, Prudent J, Paupe V, Fahiminiya S, Majewski J, Sgarioto N, Des Rosiers C, Forest A, Lin ZY, Gingras AC, Mitchell G, McBride HM, Shoubridge EA.
EMBO Mol Med. Sep 1;8(9):1019-38. doi: 10.15252/emmm.201506159. 2016
6HMN6B, SLC25A46
SLC25A46 mutations underlie progressive myoclonic ataxia with optic atrophy and neuropathy.
Charlesworth G, Balint B, Mencacci NE, Carr L, Wood NW, Bhatia KP.
Mov Disord. Aug;31(8):1249-51. doi: 10.1002/mds.26716. Epub 2016 Jul 19. 2016
7HMN6B, IMMT, SLC25A46
Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder
Abrams AJ, Hufnagel RB, Rebelo A, Zanna C, Patel N, Gonzalez MA, Campeanu IJ, Griffin LB, Groenewald S, Strickland AV, Tao F, Speziani F, Abreu L, Schüle R, Caporali L, La Morgia C, Maresca A, Liguori R, Lodi R, Ahmed ZM, Sund KL, Wang X, Krueger LA, Peng Y, Prada CE, Prows CA, Schorry EK, Antonellis A, Zimmerman HH, Abdul-Rahman OA, Yang Y, Downes SM, Prince J, Fontanesi F, Barrientos A, Németh AH, Carelli V, Huang T, Zuchner S, Dallman JE.
Nat Genet. Aug;47(8):926-32. doi: 10.1038/ng.3354. Epub 2015 Jul 13. 2015
8SLC25A33, SLC25A34, SLC25A37, SLC25A38, SLC25A39, SLC25A40, SLC25A41, SLC25A41, SLC25A42, SLC25A43, SLC25A44, SLC25A45, SLC25A46, UCP2
Fourteen novel human members of mitochondrial solute carrier family 25 (SLC25) widely expressed in the central nervous system.
Haitina T, Lindblom J, Renstrom T, Fredriksson R.
Genomics 88(6):779-90. Epub 2006 Sep 1. 2006
9APC, FAP, REEP5, SLC25A46
Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.
Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P.
Science 253(5020):665-9. 1991